EMA Authorised: Peyona (previously Nymusa) (Caffeine citrate) — Chiesi Farmaceutici SpA

View source ↗

Summary

EMA authorised Peyona (formerly Nymusa), a caffeine citrate medicine, for the treatment of apnea, with Chiesi Farmaceutici SpA as the marketing authorisation ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea

Drugs mentioned

• Peyona (caffeine citrate)

Snippet

Status: Authorised. Therapeutic area: Apnea. MAH: Chiesi Farmaceutici SpA. Decision date: 27/03/2024